| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/15/2007 | CA2621470A1 Bicyclic aromatic substituted pyridone derivative |
| 03/15/2007 | CA2621445A1 Amino acid derivatives as histone deacetylase (hdac) inhibitors |
| 03/15/2007 | CA2621443A1 Thiophene and thiazole substituted trifluoroethanone derivatives as histone deacetylase (hdac) inhibitors |
| 03/15/2007 | CA2621406A1 Pparactive compounds |
| 03/15/2007 | CA2621390A1 Iminooxazolidine derivatives and use thereof |
| 03/15/2007 | CA2621314A1 Crystalline forms of 1-chloro-4-(.beta.-d-glucopyranos-1-yl)-2-(4-ethynyl-benzyl)-benzene, methods for its preparation and the use thereof for preparing medicaments |
| 03/15/2007 | CA2621279A1 Therapeutic compositions comprising hyaluronan and therapeutic antibodies as well as methods of treatment |
| 03/15/2007 | CA2621275A1 1 , 4 and 1 , 5-disubstituted indole derivatives for use as ppar active compounds |
| 03/15/2007 | CA2621187A1 Novel diazaspiroalkanes and their use for treatment of ccr8 mediated diseases |
| 03/15/2007 | CA2621111A1 Polyalkylene glycol derivatives of 4- (phenylamino)quinazolines useful as irreversible inhibitors of epidermal gr0wth fact0r receptor tyrosine kinase |
| 03/15/2007 | CA2621057A1 Ikk inhibitors for the treatment of endometriosis |
| 03/15/2007 | CA2621055A1 Sustained-release microsphere containing short chain deoxyribonucleic acid or short chain ribonucleic acid and method of producing the same |
| 03/15/2007 | CA2621015A1 New use for a composition comprising chloroprocaine hcl, a new composition comprising chloroprocaine hcl and a method for its manufacture |
| 03/15/2007 | CA2620633A1 Modified biodegradable polymers, preparation and use thereof for making biomaterials and dressings |
| 03/15/2007 | CA2620554A1 Treatment of autoimmune diseases |
| 03/15/2007 | CA2620491A1 Pharmaceutical dosage forms and compositions comprising lecoztan |
| 03/15/2007 | CA2620472A1 Substituted benzimidazoles as kinase inhibitors |
| 03/15/2007 | CA2620164A1 Topical formulations containing o-desmethyl venlafaxine (odv) or its salts |
| 03/15/2007 | CA2618489A1 Pi3k inhibitors for the treatment of endometriosis |
| 03/15/2007 | CA2616729A1 Tetrahydro-.beta.-carbolin-sulfonamide derivatives as 5-ht6 ligands |
| 03/15/2007 | CA2616058A1 Processes for the preparation of (3r,4s)-4-((4-benzyloxy)phenyl)-1-(4-fluorophenyl)-3-((s)-3-(4-fluorophenyl)-3-hydroxypropyl)-2-azetidinone, an intermediate for the synthesis of ezetimibe |
| 03/15/2007 | CA2615888A1 Substituted pyridocarboxamides as inhibitors of plasminogen activator inhibitor 1 (pai-1) |
| 03/15/2007 | CA2610478A1 Tricyclic 6-alkylidene-penems as class-d .beta.-lactamases inhibitors |
| 03/15/2007 | CA2608444A1 Formulations containing pantoprazole free acid and its salts |
| 03/15/2007 | CA2605932A1 Dihydrobenzofuranyl alkanamine derivatives as 5ht2c agonists |
| 03/15/2007 | CA2603817A1 Compositions containing micronized tanaproget prepared by wet granulation |
| 03/15/2007 | CA2603102A1 Elastin protective polyphenolics and methods of using the same |
| 03/15/2007 | CA2597148A1 Amide derivatives as ppar activators |
| 03/14/2007 | EP1762619A2 Multiple-tumor aberrant growth genes |
| 03/14/2007 | EP1762569A1 Novel 6-amino-morphinan derivatives, method of manufacturing them and their application as analgesics |
| 03/14/2007 | EP1762568A1 Pyrazole derivatives |
| 03/14/2007 | EP1762567A1 Pyrazole derivatives for treating HIV |
| 03/14/2007 | EP1762558A1 Process for preparing transcription factors and their use |
| 03/14/2007 | EP1762557A2 Aspirin-triggered lipid mediators |
| 03/14/2007 | EP1762255A1 Coated medical devices |
| 03/14/2007 | EP1762249A2 Freeze-dried pantoprazole preparation and pantoprazole injection |
| 03/14/2007 | EP1762248A1 Use of cobalt porphyrins in joint therapy with an immunosuppressant drug for treatment of transplant patients or autoimmune disorders |
| 03/14/2007 | EP1762247A1 The use of anabolic agents, anti-catabolic agents, antioxidant agents, and analgesics for protection, treatment and repair of connective tissue in humans and animals |
| 03/14/2007 | EP1762246A1 Multivalent DTP-Polio vaccines |
| 03/14/2007 | EP1762243A1 Factor for regulation of neurite growth |
| 03/14/2007 | EP1762241A1 Compositions and methods for mitigating skin irritation |
| 03/14/2007 | EP1762240A1 Compositions for inhibiting or reducing inflammation of skin |
| 03/14/2007 | EP1762239A1 Lofexidine for intraspinal administration |
| 03/14/2007 | EP1762238A1 New association of agomelatine with a mood stabilizer, and pharmaceutical compositions comprising them |
| 03/14/2007 | EP1762237A1 Use of agomelatine for the preparation of medicaments for the treatment of sleep disorders in depressed patients |
| 03/14/2007 | EP1762236A2 Formulations of alpha adrenergic receptor antagonists and their uses |
| 03/14/2007 | EP1762235A1 Orally adminstered composition for preventing neonatal hemorrhages, in a tardy form, caused by a K-vitamin deficiency |
| 03/14/2007 | EP1762234A1 Ampk activator |
| 03/14/2007 | EP1762233A1 Preventitive for oxygen-induced damages from diving |
| 03/14/2007 | EP1762232A1 Liquid filled delivery system, preferably an HPMC capsule filled with glycerol |
| 03/14/2007 | EP1762230A1 Filmtablet or granulate comprising a pyridylpyrimidine |
| 03/14/2007 | EP1762226A2 Topical formulations in the form of gels containing acyclovir and lidocaine as active ingredients |
| 03/14/2007 | EP1762219A1 Photoprotective and/or photoimmunoprotective compositions for the skin and uses thereof |
| 03/14/2007 | EP1761551A1 Gemcitabine derivatives nanoparticles |
| 03/14/2007 | EP1761550A2 Small molecule stimulators of neuronal growth |
| 03/14/2007 | EP1761545A2 Novel unsaturated tetracyclic tetrahydrofuran derivatives |
| 03/14/2007 | EP1761542A2 Octahydropyrrolo[3,4-c]pyrrole derivatives an their use as antiviral agents |
| 03/14/2007 | EP1761541A1 Pyrrazolo-pyrimidine derivatives |
| 03/14/2007 | EP1761540A1 Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta |
| 03/14/2007 | EP1761539A1 Indole derivative and use for treatment of cancer |
| 03/14/2007 | EP1761536A1 Novel 2-benzylaminodihydropteridinones, method for producing them and use thereof as drugs |
| 03/14/2007 | EP1761533A1 1-aza-bicyclo[3.3.1]nonanes |
| 03/14/2007 | EP1761532A1 Aminocyclohexanes as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes |
| 03/14/2007 | EP1761531A1 Imidazole variants as modulators of gaba receptor for the treatment of gi disorders |
| 03/14/2007 | EP1761530A1 New derivatives of 5-aryl-1h-pyrrolo [2, 3b] pyridine-3-carboxamide or 5-aryl-1h-pyrrolo [2, 3b] pyridine-3-carboxylic acid |
| 03/14/2007 | EP1761529A2 Pyrrolopyridine derivatives and their use as crth2 antagonists |
| 03/14/2007 | EP1761527A1 Novel 9-aza-bicyclo¬3.3.1|nonane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 03/14/2007 | EP1761526A2 Thiazole derivatives as chemokine receptor antagonists |
| 03/14/2007 | EP1761525A1 Thioether derivatives, their manufacture and use as pharmaceutical agents |
| 03/14/2007 | EP1761524A1 Phenyl diazepane carboxamides and annelated phenyl piperazine carboxamides containing oxygen and used as dopamine d3 antagonists |
| 03/14/2007 | EP1761522A1 Compounds and methods for treating dyslipidemia |
| 03/14/2007 | EP1761521A1 Compounds and methods for treating dyslipidemia |
| 03/14/2007 | EP1761520A1 Kinase inhibitors |
| 03/14/2007 | EP1761519A1 Indole derivatives as histamine receptor antagonists |
| 03/14/2007 | EP1761518A1 Novel alkyl substituted piperidine derivatives as monoamine neurotransmitter re-uptake inhibitors |
| 03/14/2007 | EP1761517A1 Novel imidazoles and triazoles, the production thereof, and the use of the same as medicaments |
| 03/14/2007 | EP1761515A1 2-(hetero-)aryl substituted tetrahydroquinoline derivatives |
| 03/14/2007 | EP1761514A1 Novel tetracyclic tetrahydrofuran derivatives |
| 03/14/2007 | EP1761513A1 Tetracyclic compounds as estrogen ligands |
| 03/14/2007 | EP1761512A1 Novel alkyl substituted piperazine derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 03/14/2007 | EP1761510A1 Method for producing 4-(benzimidazolylmethylamino)-benzamidines |
| 03/14/2007 | EP1761509A2 Substituted cycloalkyl derivatives for the treatment of respiratory diseases |
| 03/14/2007 | EP1761508A1 Stereospecific anxiolytic and anticonvulsant agents with reduced muscle-relaxant, sedative-hypnotic and ataxic effects |
| 03/14/2007 | EP1761507A1 Phosphodiesterase-inhibiting compounds of the 2,3-benzodiazepine type |
| 03/14/2007 | EP1761506A1 Substituted quinazolones as anti-cancer agents |
| 03/14/2007 | EP1761505A1 Pyrimidine urea derivatives as kinase inhibitors |
| 03/14/2007 | EP1761503A2 Imidazol derivatives as tyrosine kinase inhibitors |
| 03/14/2007 | EP1761497A2 Azadecalin glucocorticoid receptor modulators |
| 03/14/2007 | EP1761496A2 Non-imidazole heterocyclic compounds as histamine h3-receptor ligands |
| 03/14/2007 | EP1761495A2 Piperidinyl prostaglandin analogs as ocular hypotensive agents |
| 03/14/2007 | EP1761494A1 Chemical compounds i |
| 03/14/2007 | EP1761493A2 Alkyl substituted piperidine derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 03/14/2007 | EP1761492A1 1-benzyl-4-¬(5,6-dimethoxy-1-indanone)-2-yl| methyl piperidine oxalate (donepezil oxalate) and its polymorphs |
| 03/14/2007 | EP1761491A1 Novel piperidine/8-azabicyclo [3.2.1] octan derivatives as moduilators of chemokine receptor ccr5 |
| 03/14/2007 | EP1761490A1 3'-alkoxy spirocyclic tetramic and tetronic acids |
| 03/14/2007 | EP1761489A1 Crystalline form of atorvastatin hemi calcium |
| 03/14/2007 | EP1761488A1 Lactam tachykinin receptor antagonists |
| 03/14/2007 | EP1761485A1 Amidino compounds as cysteine protease inhibitors |
| 03/14/2007 | EP1761482A1 Ortho-substituted (3-hydroxyphenyl)-acetic acid benzylidene hydrazides |
| 03/14/2007 | EP1761480A2 New mao-b inhibitors |